Leslie Leith

481 total citations
8 papers, 168 citations indexed

About

Leslie Leith is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Leslie Leith has authored 8 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Leslie Leith's work include Chemical Synthesis and Analysis (2 papers), Synthesis and Biological Evaluation (2 papers) and Cancer therapeutics and mechanisms (1 paper). Leslie Leith is often cited by papers focused on Chemical Synthesis and Analysis (2 papers), Synthesis and Biological Evaluation (2 papers) and Cancer therapeutics and mechanisms (1 paper). Leslie Leith collaborates with scholars based in United States and Germany. Leslie Leith's co-authors include John S. Tokarski, John T. Hunt, Janet G. Mulheron, Raj N. Misra, Ligang Qian, Sam Chao, Kevin R. Webster, Kyoung Soon Kim, S. David Kimball and John S. Sack and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Organic Process Research & Development.

In The Last Decade

Leslie Leith

8 papers receiving 163 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie Leith United States 5 70 66 51 32 16 8 168
Shelby Crawford United States 5 142 2.0× 51 0.8× 84 1.6× 28 0.9× 9 0.6× 5 245
Zhihong O’Brien United States 10 100 1.4× 34 0.5× 39 0.8× 25 0.8× 39 2.4× 12 226
Yiwen Zhang China 9 102 1.5× 53 0.8× 35 0.7× 24 0.8× 28 1.8× 28 246
Takashi Imada Japan 9 98 1.4× 84 1.3× 16 0.3× 19 0.6× 32 2.0× 9 242
Hai‐Yun Xiao United States 7 44 0.6× 87 1.3× 20 0.4× 9 0.3× 13 0.8× 9 152
Chester Yuan United States 5 54 0.8× 50 0.8× 31 0.6× 12 0.4× 40 2.5× 7 155
Hai-yun Xiao United States 6 45 0.6× 160 2.4× 42 0.8× 21 0.7× 5 0.3× 7 241
Songfeng Lu United States 6 113 1.6× 103 1.6× 24 0.5× 9 0.3× 20 1.3× 7 244
Tammy C. Wang United States 10 98 1.4× 113 1.7× 17 0.3× 18 0.6× 36 2.3× 16 278
JM Gillardin Belgium 8 38 0.5× 133 2.0× 24 0.5× 18 0.6× 8 0.5× 11 415

Countries citing papers authored by Leslie Leith

Since Specialization
Citations

This map shows the geographic impact of Leslie Leith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Leith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Leith more than expected).

Fields of papers citing papers by Leslie Leith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Leith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Leith. The network helps show where Leslie Leith may publish in the future.

Co-authorship network of co-authors of Leslie Leith

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Leith. A scholar is included among the top collaborators of Leslie Leith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Leith. Leslie Leith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Maxwell, Brad D., Samuel J. Bonacorsi, Leslie Leith, et al.. (2009). Synthesis of lead LFA‐1 antagonist [14C]spyrocyclic hydantoin. Journal of Labelled Compounds and Radiopharmaceuticals. 52(6). 236–242. 9 indexed citations
2.
Roberge, Jacques Y., Lalgudi S. Harikrishnan, Zheming Ruan, et al.. (2008). Design and Synthesis of a G-Protein-Coupled Receptor Antagonist Library of Aryloxyalkanolamines Using a Polymer-Supported Acyclic Acetal Linker. Journal of Combinatorial Chemistry. 11(1). 72–82. 4 indexed citations
3.
Tellew, John E., Leslie Leith, & Arvind Mathur. (2007). Practical Synthesis of 3-Amino-4,5-dimethylisoxazole from 2-Methyl-2-butenenitrile and Acetohydroxamic Acid. Organic Process Research & Development. 11(2). 275–277. 2 indexed citations
4.
Zhang, Huiping, Samuel J. Bonacorsi, Bang‐Chi Chen, et al.. (2005). A facile and efficient synthesis of d3‐labelled Reyataz™. Journal of Labelled Compounds and Radiopharmaceuticals. 48(14). 1041–1047. 2 indexed citations
5.
Balog, Aaron, Mark Salvati, Weifang Shan, et al.. (2004). The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(24). 6107–6111. 25 indexed citations
6.
Chen, Ping, Derek Norris, Jagabandhu Das, et al.. (2004). Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56Lck inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(24). 6061–6066. 22 indexed citations
7.
Kim, Kyoung Soon, John S. Sack, John S. Tokarski, et al.. (2000). Thio- and Oxoflavopiridols, Cyclin-Dependent Kinase 1-Selective Inhibitors:  Synthesis and Biological Effects. Journal of Medicinal Chemistry. 43(22). 4126–4134. 80 indexed citations
8.
Murugesan, Natesan, Zhengxiang Gu, Philip D. Stein, et al.. (2000). Biphenylsulfonamide Endothelin Receptor Antagonists. 2. Discovery of 4‘-Oxazolyl Biphenylsulfonamides as a New Class of Potent, Highly Selective ETA Antagonists. Journal of Medicinal Chemistry. 43(16). 3111–3117. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026